Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.
Explore this paper's citation graph
Summary
The use of uninterrupted NOACs in AF catheter ablation appears to be safe and efficacious; however, the evidence is not of high quality; thus, further high-quality RCTs are needed to confirm these findings.
- Type
- review
- Published
- 2017-11-15
- Cited by
- 14
- References
- 30
- OpenAlex
- https://openalex.org/W2742889547
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21460989
Keywords
Medicine, Atrial fibrillation, Vitamin K antagonist, Relative risk, Randomized controlled trial
References
- Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
- Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
- Beta blockade during and after myocardial infarction: an overview of the randomized trials.
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Rand
- Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon.
- Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
- Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin
- Safety of Continuous Periprocedural Rivaroxaban for Patients Undergoing Left Atrial Catheter Ablation Procedures
- Meta-analysis in clinical trials.
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis.
- Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study
- Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation.
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- Efficacy and Safety of Rivaroxaban and Warfarin in the Perioperative Period of Catheter Ablation for Atrial Fibrillation - Outcome Analysis From a Prospective Multicenter Registry Study in Japan.
- Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation
- Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin
Cited by
- The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation
- Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
- CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation
- Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation
- Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset
- Meta-Analysis Comparing Catheter-Guided Ablation Versus Conventional Medical Therapy for Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
- The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.
- Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.
- Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation
- Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
- Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions
- Post-Ablation Stroke Despite NOAC Use: Successful Reperfusion Therapy After Dabigatran Reversal with Incidental Discovery of a Large MCA Aneurysm—A Case Report
- Clinical Reviews: Electrophysiology and Ablation The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications
- ChA 2 Ds 2 -VAsc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation
Related papers
- Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
- Switching from a vitamin K antagonist to a NOAC
- INADEQUACY OF VITAMIN K ANTAGONIST USE IN PATIENTS WITH ATRIAL FIBRILLATION – OVERVIEW OF EVERYDAY CLINICAL PRACTICE AT THE MERKUR UNIVERSITY HOSPITAL IN ZAGREB, CROATIA
- Diet and Parkinson's disease: A potential role of dairy products in men
- Can dietary saturated fat be beneficial in prevention of stroke risk? A meta-analysis
- Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies.
- Macronutrients intake and risk of Parkinson's disease: A meta‐analysis
- Sugar sweetened beverages consumption and risk of coronary heart disease: a meta-analysis of prospective studies.